MKI67 and breast carcinoma: These data are in line with our observations in human where we found that women with higher risk of breast cancer (e.g., nulliparous women and BRCA1/2 mutation carriers) have higher fraction of p27+ mammary epithelial cells and also higher fraction of Ki67+ proliferative cells [3].